| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.9M | -0.7% |
| Cost of Revenue | $10.5M | -4.3% |
| Gross Profit | $73.4M | -0.1% |
| R&D Expense | $2.4M | +13.9% |
| SG&A Expense | $18.1M | -0.1% |
| Operating Income | $18.5M | +18.8% |
| Pre-tax Income | $19.1M | +11.5% |
| Income Tax | $5.4M | +5.9% |
| Net Income | $13.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | +8.6% |
| Accounts Receivable | $12.8M | -1.1% |
| Current Assets | $31.8M | +3.3% |
| Total Assets | $54.7M | -1.2% |
| Current Liabilities | $36.5M | +6.7% |
| Total Liabilities | $50.4M | +8.3% |
| Stockholders' Equity | -$462K | -111.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.1M | +97.7% |
| Capital Expenditures | $177K | -30.6% |
| Investing Cash Flow | -$177K | -353.8% |
| Financing Cash Flow | -$19.0M | -34.1% |
| Free Cash Flow | $20.9M | +100.8% |
| +9.7% |
| EPS (Basic) | $1.08 | +30.1% |
| EPS (Diluted) | $1.06 | +27.7% |